This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Crispr Therapeutics Ag. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Matthias Johannes John: Innovator in Alpha-1 Antitrypsin Deficiency Treatment
Introduction
Matthias Johannes John is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical treatment, particularly focusing on Alpha-1 antitrypsin deficiency (AATD). His innovative work has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Matthias holds 1 patent for his invention titled "Materials and methods for treatment of alpha-1 antitrypsin deficiency." This patent outlines materials and methods for treating patients with AATD both ex vivo and in vivo. Additionally, it provides techniques for editing the SERPINA1 gene in a cell through genome editing, showcasing his commitment to advancing medical science.
Career Highlights
Matthias is currently associated with Crispr Therapeutics AG, a company known for its pioneering work in gene editing technologies. His role at the company allows him to collaborate with other leading scientists and contribute to groundbreaking research in genetic therapies.
Collaborations
Matthias has worked alongside esteemed colleagues such as Chad Albert Cowan and Roman Lvovitch Bogorad. Their combined expertise enhances the innovative environment at Crispr Therapeutics AG, fostering advancements in the treatment of genetic disorders.
Conclusion
Matthias Johannes John is a key figure in the development of treatments for Alpha-1 antitrypsin deficiency. His patent and work at Crispr Therapeutics AG highlight his dedication to improving patient outcomes through innovative medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile